JOHNSON & JOHNSON — Director's Dealing 2020

Feb 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2020-02-13

Reporting Person: Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-13	Common Stock	M	8360.0000	—	Acquired	108089.0010	Direct
2020-02-13	Common Stock	M	7724.0000	—	Acquired	115813.0010	Direct
2020-02-13	Common Stock	F	3951.0000	$150.4600	Disposed	111862.0010	Direct
2020-02-13	Common Stock	F	4277.0000	$150.4600	Disposed	107585.0010	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-13	Performance Share Units	$	M	8360.0000	Disposed		Common Stock (8360.0000)	Direct
2020-02-13	Restricted Share Units	$	M	7724.0000	Disposed		Common Stock (7724.0000)	Direct

Footnotes

F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting.

F2: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting.

F3: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

F4: Shares withheld for payment of taxes upon vesting of Performance Share Units.